Design, virtual screening and synthesis of PPAR agonists

被引:0
|
作者
Feng, J [1 ]
Guo, YS
Lu, Y
Guo, ZR
机构
[1] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China
[2] Peking Union Med Coll, Beijing 100050, Peoples R China
关键词
PPAR agonist; virtual screening; DOCK;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The PPARs are members of the nuclear hormone receptor super family. A novel virtual library of PPAR agonists by structure-based drug design and combinatorial library method was described. The PPAR-LBD 3D model used for virtual screening was built by the 1K74 and 1K71 crystal structure. After DOCK program screening, which automatically simulated the interaction between the ligands and receptors, the strong-binding virtual compounds were selected and synthesized. Nine new compounds have been synthesized. Three of them exhibitpotent dual PPARalpha/gamma agonist activity as demonstrated by in vitro binding. The activity data offered detailed molecular information for design and synthesis of new compounds.
引用
收藏
页码:1544 / 1550
页数:7
相关论文
共 12 条
  • [1] Non thiazolidinedione antihyperglycaemic agents .1. alpha-heteroatom substituted beta-phenylpropanoic acids
    Buckle, DR
    Cantello, BCC
    Cawthorne, MA
    Coyle, PJ
    Dean, DK
    Faller, A
    Haigh, D
    Hindley, RM
    Jefcott, LJ
    Lister, CA
    Pinto, IL
    Rami, HK
    Smith, DG
    Smith, SA
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (17) : 2121 - 2126
  • [2] N-(2-benzoylphenyl)-L-tyrosine PPARγ agonists.: 3.: Structure-activity relationship and optimization of the N-aryl substituent
    Cobb, JE
    Blanchard, SG
    Boswell, EG
    Brown, KK
    Charifson, PS
    Cooper, JP
    Collins, JL
    Dezube, M
    Henke, BR
    Hull-Ryde, EA
    Lake, DH
    Lenhard, JM
    Oliver, W
    Oplinger, J
    Pentti, M
    Parks, DJ
    Plunket, KD
    Tong, WQ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (25) : 5055 - 5069
  • [3] N-(2-benzoylphenyl)-L-tyrosine PPARγ agonists.: 2.: Structure-activity relationship and optimization of the phenyl alkyl ether moiety
    Collins, JL
    Blanchard, SG
    Boswell, GE
    Charifson, PS
    Cobb, JE
    Henke, BR
    Hull-Ryde, EA
    Kazmierski, WM
    Lake, DH
    Leesnitzer, LM
    Lehmann, J
    Lenhard, JM
    Orband-Miller, LA
    Gray-Nunez, Y
    Parks, DJ
    Plunkett, KD
    Tong, WQ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (25) : 5037 - 5054
  • [4] Structure of the PPARα and -γ ligand binding domain in complex with AZ 242;: Ligand selectivity and agonist activation in the PPAR family
    Cronet, P
    Petersen, JFW
    Folmer, R
    Blomberg, N
    Sjöblom, K
    Karlsson, U
    Lindstedt, EL
    Bamberg, K
    [J]. STRUCTURE, 2001, 9 (08) : 699 - 706
  • [5] DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases
    Ewing, TJA
    Makino, S
    Skillman, AG
    Kuntz, ID
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2001, 15 (05) : 411 - 428
  • [6] N-(2-benzoylphenyl)-L-tyrosine PPARγ agonists.: 1.: Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents
    Henke, BR
    Blanchard, SG
    Brackeen, MF
    Brown, KK
    Cobb, JE
    Collins, JL
    Harrington, WW
    Hashim, MA
    Hull-Ryde, EA
    Kaldor, I
    Kliewer, SA
    Lake, DH
    Leesnitzer, LM
    Lehmann, JM
    Lenhard, JM
    Orband-Miller, LA
    Miller, JF
    Mook, RA
    Noble, SA
    Oliver, W
    Parks, DJ
    Plunket, KD
    Szewczyk, JR
    Willson, TM
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (25) : 5020 - 5036
  • [7] LEMANN JM, 1995, BIOL CHEM, V270, P12953
  • [8] Isoxazolidine-3,5-dione and noncyclic 1,3-dicarbonyl compounds as hypoglycemic agents
    Shinkai, H
    Onogi, S
    Tanaka, M
    Shibata, T
    Iwao, M
    Wakitani, K
    Uchida, I
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (11) : 1927 - 1933
  • [9] *TRIP ASS INC, 1998, PROGR SYB 6 8
  • [10] Medical significance of peroxisome proliferator-activated receptors
    Vamecq, J
    Latruffe, N
    [J]. LANCET, 1999, 354 (9173): : 141 - 148